期刊文献+

20例经皮冠状动脉腔内成形术 被引量:5

Percutaneous transluminal coronary angioplasty:report of 20 cases
下载PDF
导出
摘要 目的:总结经皮冠状动脉腔内成形术(PTCA)的经验以求改善PTCA技术,提高临床PTCA的成功率。方法:PTCA按Gruntzig方法进行。结果:对20例严重冠状动脉硬化性心脏病患者进行PT-CA,共计30支39处血管病变中的26支35处病变进行了有效扩张,平均扩张次数3.5±2.6次/处,扩张时间65±21秒/次,扩张压力每次7.5±2.3atm。平均狭窄程度由87%减轻至15%,狭窄完全消失的病变有28处。1例术中发生急性冠状动脉闭塞,经植入支架后恢复正常,未发生其它严重并发症。总成功率100%。术后心绞痛、心电图缺血性STT改变消失或减轻。结论:PTCA具有创伤小、疗效确切和较安全等优点;植入冠状动脉内支架是处理PTCA所致急性冠状动脉闭塞的有效方法;对于有指征的陈旧性心肌梗塞患者也宜积极采取PTCA的治疗,有助于提高生活质量。 Objective:To summarize the experience of percutaneous transluminal coronary angioplasty (PTCA) for improving the PTCA technique and increasing its rate of success.Methods:PTCA (Gruntzig method) was performed in 20 patients with severe coronary heart disease.Results:The procedure was done for 39 lesions of 30 diseased vessels.Among the 39 lesions,13 were of type A,and 26 type B and type C.Effective dilatation was performed in 26 to the 30 diseased vessels and 35 of the 39 lesions (type A lesions:13;type B and C:22).The average number of times of dilatation was 3.5±2.6, the average duration of dilatation was 65±21 seconds and the average dilatation pressure was 7 5±2 3atm.After PTCA,the average severity of the coronary artery stenosis decreased from 87% to 15%,the stenosis disappeared completely in 28 lesions.Coronary stent was implanted with the aim of treating acute coronary occlusion during PTCA in one patient,who recovered without other serious complication.The ischemic STT wave changes disappeared or were improved in all patients after PTCA.The overall rate of success was 100%.Conclusions:PTCA has the advantages of being not very invasive and comparatively safe,and having a definite therapeutic effectiveness,hence it can be used as an active treatment in old myocardial infarction when indicated.PTCA may help improve the patient's life quality and prognosis.
出处 《中国危重病急救医学》 CAS CSCD 1997年第2期78-80,共3页 Chinese Critical Care Medicine
关键词 心脏病 冠状动脉硬化性 冠状动脉支架 coronary heart disease percutaneous trans iuminal coronary angioplasty coronary stent
  • 相关文献

同被引文献22

  • 1叶云,杨宇,韩卓辉,刘军.前列地尔脂微球载体注射液预防老年人造影剂肾病的临床观察[J].中国新药杂志,2006,15(16):1386-1389. 被引量:8
  • 2[1]Sorrentino MJ.Cholesterol reduction to prevent CAD.What do the data show[J]? Postgrad Med,2000,108(7):40-42,45-46,49-52.
  • 3[2]Expert Panel on Detection,Evaluation,and Treatment of High Blood Cholesterol in Adults.Executive summary of the third report of the National Cholesterol Education Program (NCEP) expert panel on detection,evaluation,and treatment of high blood cholesterol in adults (adults treatment panel Ⅲ)[J].JAMA,2001,285 (19):2486-2497.
  • 4[3]Sacks FM.The role of high-density lipoprotein (HDL) cholesterol in the prevention and treatment of coronary heart disease:expert group recommendations[J].Am J cardiol,2002,90(2):139-143.
  • 5[4]Austin MA.Epidemiology of hypertriglyceridemia and cardiovascular disease[J].Am J Cardiol,1999,83(9B):13F-16F.
  • 6[6]Grundy SM,Benjamin IJ,Burke GL,et al.Diabetes and cardiovascular disease:a statement for healthcare professionals from the American Heart Association[J].Circulation,1999,100 (10):1134-1146.
  • 7[7]Le Feuvre C,Borentain M,Beygui F,et al.Comparison of short-and long-term outcomes of coronary angioplasty in patients with and without diabetes mellitus and with and without hemodialysis[J].Am J Cadiol,2003,92 (6):721-725.
  • 8[11]Zimarino M,Renda G,De Caterina R.Optimal duration of antiplatelet therapy in recipients of coronary drug-eluting stems[J].Drugs,2005,65(6):725-732.
  • 9魏刘华,心血管病学进展,1995年,16卷,269页
  • 10罗向东,中华创伤杂志,1994年,10卷,4期,185页

引证文献5

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部